Immune responses to a class II helper peptide epitope in patients with stage III/IV resected melanoma. [electronic resource]
Producer: 20050307Description: 5004-13 p. digitalISSN:- 1078-0432
- Age Factors
- Alleles
- Antigens, Neoplasm
- CD3 Complex -- biosynthesis
- CD4 Antigens -- biosynthesis
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cancer Vaccines -- chemistry
- Cell Line, Tumor
- Cell Proliferation
- Dendritic Cells -- cytology
- Enzyme-Linked Immunosorbent Assay
- Epitopes -- chemistry
- Female
- Flow Cytometry
- Granzymes
- HLA Antigens -- chemistry
- HLA-DR Antigens -- genetics
- Humans
- Immunotherapy -- methods
- Leukocytes, Mononuclear -- immunology
- Lipid A -- analogs & derivatives
- Lymphocytes -- metabolism
- MART-1 Antigen
- Male
- Melanoma -- metabolism
- Microscopy, Fluorescence
- Neoplasm Proteins -- chemistry
- Peptides -- chemistry
- Pilot Projects
- Saponins -- pharmacology
- Serine Endopeptidases -- chemistry
- T-Lymphocytes -- metabolism
- Th1 Cells -- immunology
- Th2 Cells -- immunology
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.